Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other: > Other > Other: > Cardiovascular medicaments: > Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3004.90.92.24
Argatroban Injection 2.5mg/mL Vial
Sterile injectable solution of argatroban, a direct thrombin inhibitor used for anticoagulation in patients with heparin-induced thrombocytopenia. Classified under HTS 3004.90.92.24 as a cardiovascular medicament containing argatroban, put up in measured doses for therapeutic use. It is unmixed and prepared for IV administration in hospital settings.
Adenosine Injection 6mg/2mL Vial
Pre-filled syringe or vial of adenosine for rapid IV push to terminate paroxysmal supraventricular tachycardia. Falls under HTS 3004.90.92.24 as a cardiovascular medicament containing adenosine, in measured doses for acute therapeutic use. Essential for emergency cardiac rhythm management.
Dobutamine HCl 12.5mg/mL Injection
Concentrated injectable dobutamine hydrochloride for dilution, used as inotrope in heart failure and shock. Covered by HTS 3004.90.92.24 as cardiovascular medicament with dobutamine salts in measured vial doses. Critical care drug for cardiogenic shock therapy.
Phenoxybenzamine HCl 10mg Capsules
Hard gelatin capsules containing phenoxybenzamine hydrochloride, an alpha-blocker for pheochromocytoma and hypertensive emergencies. HTS 3004.90.92.24 due to specific inclusion of phenoxybenzamine salts as cardiovascular medicaments in retail doses. Rare but essential orphan drug.
Amlodipine 10mg Extended-Release Tablets
Once-daily extended-release formulation of amlodipine besylate for 24-hour blood pressure control. Remains under HTS 3004.90.92.24 as listed cardiovascular medicament despite modified release profile. Patient-friendly compliance aid for chronic hypertension.
Argatroban 1mg/mL Ready-to-Use Infusion Bags
Premixed, pharmacy-ready infusion bags of argatroban for continuous anticoagulation therapy. HTS 3004.90.92.24 classification for cardiovascular medicaments containing argatroban in measured doses. Reduces preparation errors in critical care settings.
Esmolol 250mg/mL Concentrate for Injection
High-concentration esmolol HCl vials requiring dilution before IV use in emergency settings. Specific HTS 3004.90.92.24 listing for esmolol salt cardiovascular medicaments in measured doses. Rapid titration allows precise hemodynamic control.
Adenosine Stress Test 3mg/mL Vials
Diagnostic dose vials of adenosine for pharmacologic cardiac stress testing in nuclear medicine. Still classified under HTS 3004.90.92.24 as therapeutic cardiovascular medicament despite diagnostic use context. Measured doses for controlled coronary vasodilation.
Amlodipine Besylate 5mg Tablets
Oral tablets of amlodipine besylate, a calcium channel blocker for hypertension and angina management. Classified in HTS 3004.90.92.24 due to specific listing of amlodipine salts as cardiovascular medicaments in measured doses for retail sale. Commonly prescribed for chronic cardiovascular therapy.
Esmolol Hydrochloride 10mg/mL IV Solution
Ready-to-use IV infusion bags of esmolol HCl, a short-acting beta-blocker for intraoperative and ICU blood pressure control. HTS 3004.90.92.24 classification as cardiovascular medicament containing esmolol salts in measured doses. Used for acute supraventricular tachycardia and hypertension.